The accuracy of ClariSarco is based on AI Deep Learning Technology and automatically measures the density of skeletal muscle from abdominal CT images.
ClariSarco’s abdominal muscle analysis helps determine Sarcopenia & Myosteatosis at an early stage, and allow continuous muscle quantity & quality assessments for monitoring of changes in muscle status.
ClariSarco Benefits
Helps predict the risk of developing metabolic syndrome
- A system that predicts the risk of developing metabolic syndrome.
- Standalone S/W analyzing DICOM CT abdomen fat image data set.
Full Automated Operation (no operator needed)
- Fully compliant with DICOM: compatible with all CT and PACS systems.
- Simple installation and fast operation via GPU computer.
Operating Costs Reduction
- No need to change the existing CT scanners.